Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy Pratt

Showing results (51-60 of 134) with videos related to

Pageof 14
Sort By:
Oncotarget|February 6, 2014
A novel Cdk9 inhibitor preferentially targets tumor cells and synergizes with fludarabineElisabeth Walsby, Guy Pratt, Hao Shao, et al.
British Journal of Haematology|January 21, 2017
Guidelines for screening and management of late and long-term consequences of myeloma and its treatmentJohn A Snowden, Diana M Greenfield, Jennifer M Bird, et al.
British Journal of Haematology|September 9, 2024
Advanced imaging for earlier diagnosis and morbidity prevention in multiple myeloma: A British Society of Haematology and UK Myeloma Society Good Practice PaperMartin Kaiser, Vicky Goh, Simon Stern, et al.
Blood Advances|November 24, 2020
Renal outcome in patients with newly diagnosed multiple myeloma: results from the UK NCRI Myeloma XI trialRitika Rana, Paul Cockwell, Mark Drayson, et al.
Plos Pathogens|March 4, 2021
PD-1 is imprinted on cytomegalovirus-specific CD4+ T cells and attenuates Th1 cytokine production whilst maintaining cytotoxicityHelen M Parry, Alexander C Dowell, Jianmin Zuo, et al.
British Journal of Haematology|April 27, 2011
Guidelines for supportive care in multiple myeloma 2011John A Snowden, Sam H Ahmedzai, John Ashcroft, et al.
Haematologica|May 13, 2010
CD8(+) T-cell immunity against cancer-testis antigens develops following allogeneic stem cell transplantation and reveals a potential mechanism for the graft-versus-leukemia effectAndrew McLarnon, Karen P Piper, Oliver C Goodyear, et al.
Oncotarget|September 23, 2016
NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphomaHelen M Parry, Tom Stevens, Ceri Oldreive, et al.
Stem Cell Research & Therapy|March 29, 2025
Examining the effect of intermittent cycling throughout a 3-h period on peripheral blood concentrations of haemopoietic stem and progenitor cells and cytolytic natural killer cellsPhoebe A Cox, Fendi Pradana, Ella Noble, et al.
Haematologica|July 10, 2025
PHF6 interacts with the LMO2 complex in T-cell acute lymphoblastic leukemiaVesna S Stanulović, Sarah Binhassan, Budoor A Jaber, et al.
Pageof 14

Showing results (51-60 of 134) with videos related to

Sort By:
Pageof 14
Oncotarget|February 6, 2014
A novel Cdk9 inhibitor preferentially targets tumor cells and synergizes with fludarabineElisabeth Walsby, Guy Pratt, Hao Shao, et al.
British Journal of Haematology|January 21, 2017
Guidelines for screening and management of late and long-term consequences of myeloma and its treatmentJohn A Snowden, Diana M Greenfield, Jennifer M Bird, et al.
British Journal of Haematology|September 9, 2024
Advanced imaging for earlier diagnosis and morbidity prevention in multiple myeloma: A British Society of Haematology and UK Myeloma Society Good Practice PaperMartin Kaiser, Vicky Goh, Simon Stern, et al.
Blood Advances|November 24, 2020
Renal outcome in patients with newly diagnosed multiple myeloma: results from the UK NCRI Myeloma XI trialRitika Rana, Paul Cockwell, Mark Drayson, et al.
Plos Pathogens|March 4, 2021
PD-1 is imprinted on cytomegalovirus-specific CD4+ T cells and attenuates Th1 cytokine production whilst maintaining cytotoxicityHelen M Parry, Alexander C Dowell, Jianmin Zuo, et al.
British Journal of Haematology|April 27, 2011
Guidelines for supportive care in multiple myeloma 2011John A Snowden, Sam H Ahmedzai, John Ashcroft, et al.
Haematologica|May 13, 2010
CD8(+) T-cell immunity against cancer-testis antigens develops following allogeneic stem cell transplantation and reveals a potential mechanism for the graft-versus-leukemia effectAndrew McLarnon, Karen P Piper, Oliver C Goodyear, et al.
Oncotarget|September 23, 2016
NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphomaHelen M Parry, Tom Stevens, Ceri Oldreive, et al.
Stem Cell Research & Therapy|March 29, 2025
Examining the effect of intermittent cycling throughout a 3-h period on peripheral blood concentrations of haemopoietic stem and progenitor cells and cytolytic natural killer cellsPhoebe A Cox, Fendi Pradana, Ella Noble, et al.
Haematologica|July 10, 2025
PHF6 interacts with the LMO2 complex in T-cell acute lymphoblastic leukemiaVesna S Stanulović, Sarah Binhassan, Budoor A Jaber, et al.
Pageof 14